Lmr Partners LLP Takeda Pharmaceutical CO LTD Transaction History

Lmr Partners LLP

$8.3 Billion
Q1 2025

A detailed history of Lmr Partners LLP transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Lmr Partners LLP holds 113,395 shares of TAK stock, worth $1.73 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

113,395

Previous 230,000 50.7%

Holding current value

$1.73 Million

Previous $3.05 Million 44.63%

% of portfolio

0.02%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$12.89 - $15.19 $1.5 Million - $1.77 Million	-116,605 Reduced 50.7%	113,395 $1.69 Million
Q4 2024 Feb 14, 2025	BUY	$13.01 - $14.43 $2.99 Million - $3.32 Million	230,000 New	230,000 $3.05 Million
Q1 2024 May 15, 2024	BUY	$13.89 - $15.04 $2.47 Million - $2.68 Million	178,128 Added 191.5%	271,143 $3.77 Million
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $4.92 Million - $5.68 Million	-368,089 Reduced 79.83%	93,015 $1.33 Million
Q3 2023 Nov 14, 2023	BUY	$15.03 - $16.32 $5.44 Million - $5.91 Million	362,114 Added 365.81%	461,104 $7.13 Million
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $1.54 Million - $1.69 Million	98,990 New	98,990 $1.56 Million
Q4 2022 Feb 14, 2023	SELL	$12.42 - $15.62 $5.43 Million - $6.83 Million	-437,205 Reduced 74.28%	151,409 $2.36 Million
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $7.53 Million - $16.9 Million	588,614 New	588,614 $7.66 Million
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $6.88 Million - $7.79 Million	-507,814 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $2.53 Million - $3.15 Million	191,800 Added 60.69%	507,814 $6.92 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $8.43 Million - $8.93 Million	-517,442 Reduced 62.08%	316,014 $5.25 Million
Q2 2021 Aug 16, 2021	BUY	$16.55 - $18.64 $10.9 Million - $12.3 Million	657,812 Added 374.51%	833,456 $13.9 Million
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $2.94 Million - $3.5 Million	175,644 New	175,644 $3.2 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $37.7 Million - $46.4 Million	-2,446,614 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $15.5 Million - $17.4 Million	-904,528 Reduced 26.99%	2,446,614 $43.4 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $1.35 Million - $1.81 Million	-92,843 Reduced 2.7%	3,351,142 $59.7 Million
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $22.5 Million - $35.1 Million	1,727,583 Added 100.65%	3,443,985 $53.4 Million
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $13.8 Million - $17.1 Million	-820,482 Reduced 32.34%	1,716,402 $33.9 Million
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $32.7 Million - $36.5 Million	-2,026,707 Reduced 44.41%	2,536,884 $43.3 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $52.6 Million - $65 Million	3,171,256 Added 227.77%	4,563,591 $80.9 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $23.3 Million - $30 Million	1,392,335 New	1,392,335 $28.4 Million

Others Institutions Holding TAK

# of Institutions

360

Shares Held

67.4M

Call Options Held

1.72M

Put Options Held

186K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $47.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account